Analyst Update: The ADT Corporation, Esperion Therapeutics Inc, and Micron Technology, Inc.

Analysts adjusted their ratings on ADT Corp (ADT), Esperion Therapeutics Inc (ESPR), and Micron Technology, Inc. (MU)

by Griffin Kruse

Published on Feb 17, 2015 at 11:28 AM
Updated on Apr 20, 2015 at 5:32 PM

Analysts are weighing in today on home security specialist ADT Corp (NYSE:ADT), biotech issue Esperion Therapeutics Inc (NASDAQ:ESPR), and semiconductor concern Micron Technology, Inc. (NASDAQ:MU). Here's a quick look at today's brokerage notes on ADT, ESPR, and MU.

  • ADT is up 1.4% this morning to hit a yearly high of $38.72, after CEO Naren Gursahaney said he expects the firm to increase its North American subscriber base this fiscal year. Subsequently, Oppenheimer raised its rating on the equity to "outperform" from "perform." On the charts, ADT Corp has added about 23.7% year-over-year. However, 22.9% of the stock's available float is sold short, which would take nearly three weeks to cover, at average trading volumes. A mass exodus of shorts could propel ADT even higher.

  • Late yesterday, Stifel raised its price target on ESPR by $30 to $90 while reiterating a "buy" prediction, prompting the shares to hit an all-time high of $69.98 -- a 4.3% gain on the day so far. Although the price-target hike may appear drastic, Esperion Therapeutics Inc has skyrocketed over the past four months, adding over 238% since Oct. 16. Accordingly, calls are popular in the stock's options pits -- over the last 50 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), 3.62 ESPR calls have been bought to open for every put.

  • Last night, Jefferies and RBC both raised their price targets on MU (to $45 and $44, respectively), with the former underscoring a "buy" rating and the latter reiterating an "outperform" rating. As such, the stock has added 2.3% today to reach $32.58. Looking back, the shares of Micron Technology, Inc. have been steadily rising, with the security up about 28.2% year-over-year. Despite MU's impressive technical output, sentiment in the options pits has reached a bearish peak, as the stock's 10-day ISE/CBOE/PHLX put/call volume ratio of 0.79 is the highest such reading taken over the past year. Should MU continue its ascent on the charts, a capitulation amongst options bears could provide tailwinds.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....
Tiffany Stock Drops as Takeover Talks Dissipate
LVMH was to acquire Tiffany & Co in a billion-dollar deal
Coty Stock Glows Up with Possible Kardashian Cosmetics Line
The trendy cosmetics company is in talks with reality TV star Kim Kardashian West over a line of beauty products
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.